STOCKHOLDERS' DEFICIT (Tables)

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Schedule of Assumptions Used to Calculate Fair Value of Options

The following assumptions were used to calculate the fair value of the Successor Company's options on the date of grant:

	Period from May 2, 2019 through December 31,
	2019
Expected volatility	44% – 45%
Expected life in years	4.0 – 4.1
Risk-free interest rate	1.40% – 2.02%
Dividend yield	—%

Schedule of Stock Options Outstanding and Stock Option Activity

The following table presents a summary of the Successor Company's stock options outstanding at and stock option activity during the period from May 2, 2019 through December 31, 2019 ("Price" reflects the weighted average exercise price per share):

(In thousands, except per share data)	Options		Price	Weighted Average Remaining Contractual Term
Granted	5,656		18.93
Forfeited	(9	)	19.00
Expired	(2	)	19.00
Outstanding, December 31, 2019 (Successor)	5,645		18.93	5.4 years
Exercisable	1,128		18.96	5.4 years
Expected to Vest	4,517		18.92	5.4 years

Summary of Unvested Options and Changes

A summary of the Successor Company's unvested options and changes during the period from May 2, 2019 through December 31, 2019 is presented below:

(In thousands, except per share data)	Options		Weighted Average Grant Date Fair Value
Granted	5,656		5.28
Vested (1)	(1,130	)	5.27
Forfeited	(9	)	5.27
Unvested, December 31, 2019 (Successor)	4,517		5.28

(1) The total fair value of the options vested during the period from May 2, 2019 through December 31, 2019 (Successor) was$6.0 million.

Summary of Restricted Stock Outstanding and Restricted Stock Activity

The following table presents a summary of the Successor Company's restricted stock outstanding and restricted stock activity as of and during the year ended December 31, 2019 (“Price” reflects the weighted average share price at the date of grant):

(In thousands, except per share data)	Awards		Price
Granted	3,301		16.47
Vested (restriction lapsed)	(644	)	16.48
Forfeited	(9	)	16.50
Outstanding, December 31, 2019 (Successor)	2,648		16.47

Schedule of Stock by Class

The following table presents the balances of the Predecessor Company's Class A, Class B, Class C and Class D Common Stock as of December 31, 2019 (Successor) and December 31, 2018 (Predecessor):

(In thousands, except share and per share data)	Successor Company	Predecessor Company
	December 31, 2019	December 31, 2018
Predecessor Class A Common Stock, par value $.001 per share, authorized 400,000,000 shares, no shares issued in 2019 and 32,292,944 shares issued in 2018	—	32
Predecessor Class B Common Stock, par value $.001 per share, authorized 150,000,000 shares, no shares issued in 2019 and 555,556 shares issued in 2018	—	1
Predecessor Class C Common Stock, par value $.001 per share, authorized 100,000,000 shares, no shares issued in 2019 and 58,967,502 shares issued in 2018	—	59
Predecessor Class D Common Stock, par value $.001 per share, authorized 200,000,000 shares, no shares issued in 2019 and 2018	—	—

Successor Common Stock and Special Warrants

The following table presents the Successor Company's Class A Common Stock, Class B Common Stock and Special Warrants issued and outstanding as of December 31, 2019:

(In thousands, except share and per share data)	December 31, 2019
Successor Class A Common Stock, par value $.001 per share,1,000,000,000 shares authorized	57,776,204
Successor Class B Common Stock, par value $.001 per share, 1,000,000,000 shares authorized	6,904,910
Successor Special Warrants	81,046,593
Total Successor Class A Common Stock, Class B Common Stock and Special Warrants issued and outstanding	145,727,707

Schedule of Loss Per Share

(In thousands, except per share data)	Successor Company			Predecessor Company
	Period from May 2, 2019 through December 31,			Period from January 1, 2019 through May 1,		Year Ended December 31,
	2019			2019		2018			2017
NUMERATOR:
Net income (loss) attributable to the Company – common shares	$	112,548		$	11,184,141	$	(201,910	)	$	(398,060	)
Exclude:
Income (loss) from discontinued operations, net of tax	$	—		$	1,685,123	$	(164,667	)	$	197,297
Noncontrolling interest from discontinued operations, net of tax - common shares	—			19,028		124			59,425
Total income (loss) from discontinued operations, net of tax - common shares	$	—		$	1,704,151	$	(164,543	)	$	256,722
Total income (loss) from continuing operations	$	112,548		$	9,479,990	$	(37,367	)	$	(654,782	)
Noncontrolling interest from continuing operations, net of tax - common shares	(751		)	—		605			1,226
Income (loss) from continuing operations	$	113,299		$	9,479,990	$	(37,972	)	$	(656,008	)
DENOMINATOR(1):
Weighted average common shares outstanding - basic	145,608			86,241		85,412			84,967
Stock options and restricted stock(2):	187			—		—			—
Weighted average common shares outstanding - diluted	145,795			86,241		85,412			84,967
Net income (loss) attributable to the Company per common share:
From continuing operations - Basic	$	0.77		$	109.92	$	(0.44	)	$	(7.71	)
From discontinued operations - Basic	$	—		$	19.76	$	(1.93	)	$	3.02
From continuing operations - Diluted	$	0.77		$	109.92	$	(0.44	)	$	(7.71	)
From discontinued operations - Diluted	$	—		$	19.76	$	(1.93	)	$	3.02

⁽¹⁾  All of the outstanding Special Warrants issued at emergence are included in both the basic and diluted weighted average common shares outstanding of the Successor Company for the period from May 2, 2019 through December 31, 2019.

⁽²⁾  Outstanding equity awards representing 5.9 million shares of Class A common stock of the Successor Company for the period from May 2, 2019 through December 31, 2019 were not included in the computation of diluted earnings per share because to do so would have been antidilutive. Outstanding equity awards representing 5.9 million, 7.2 million and 8.3 million shares of Class A common stock of the Predecessor Company for the period for the period from January 1, 2019 through May 1, 2019, the year ended December 31, 2018 and the year ended December 31, 2017, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.